BPC-157 is a synthetic peptide derived from a protein found in gastric juice, primarily investigated for its potent tissue-healing and regenerative properties. Its proposed mechanism involves promoting angiogenesis (new blood vessel formation) and upregulating growth factors, which accelerates the repair of muscle, tendon, ligament, and gut lining. From a healthspan perspective, its value lies in enhancing recovery from injuries, thereby maintaining physical function and mobility, rather than directly targeting core aging pathways.
Verdict
A potent but unproven repair tool; high risk due to unregulated status.
HEALTHSPAN IMPACT
Experimental
RISK LEVEL
Very High
EVIDENCE GRADE
C
MONTHLY COST
$120 - $250
Protocol
- Inject 250-500 mcg subcutaneously once or twice daily for targeted tissue repair.
- Take 500 mcg orally once or twice daily for systemic or gut-related benefits.
- Typically used in short cycles (2-4 weeks) to address specific injuries, not continuously.
Flags
- Not approved for human consumption by the FDA or other major regulatory bodies.
- Sourced from unregulated 'research chemical' suppliers with potential purity and safety issues.
- Banned by the World Anti-Doping Agency (WADA) as a prohibited substance.
- Long-term effects and safety profile in humans are completely unknown.
- Theoretically, its pro-angiogenic effects could promote the growth of existing undiagnosed cancers.